Company History

2010s

2018

●Passed general US FDA API facility GMP inspection.

2017

●Passed Taiwan FDA inspection and obtained GMP certificate.

●Passed PMDA audit and obtained GMP certificate.

2015

●Passed general US FDA API facility GMP inspection.

2014

●Approval for OHSAS18001&CNS15506 certification by AFNOR Group.

2013

●Passed PMDA audit and obtained GMP certificate.

2012

●Passed general US FDA API facility GMP inspection.

●Passed Taiwan FDA inspection received award for Excellence in Good Distribution Practices

2011

●October 2011 ~ March 2013 Ministry of Economic Affairs' leading new product development program "Low Voltage Cholesterol Liquid Crystal Materials".

●Cash increase to issue new shares of NT$40 million, capital increase from earnings, capital increase to $NT 4,2373,4430.
●Products Acyclovir, Diclofenac Sodium, Mefenamic Acid, Miconazole Nitrate and Sodium Starch Glycolate (DST) pass Taiwan FDA inspection.
●Passed IPEA GMP inspection, confirming conformance of our excipient DST to Good Manufacturing Practice.
●Obtained Certificate of Suitability (CEP) for product Mefenamic Acid from EDQM.

2010

●Introduced SAP system software and ERP system integration.
●Looking forward to future business development, new shares are issued from surplus. Capital increased to 3,6355,6600.。

2000s

2009

●Passed inspection by UK MHRA and obtained GMP certificate. Passed Japanese PMDA and obtained GMP certificate.

2008

●Obtained Halal certification and Kosher certification.

2007

●Passed general US FDA API facility GMP inspection (6th inspection).

2005

●Introduction of WorkFlow system software and integration with ERP, further increasing system efficiencies.

2004

●Introduction of ERP enterprise resource planning software.

2003

●Development of low-viscosity fluorine-containing negative liquid crystal series products, associated intermediates and monomers.

2002

●Acyclovir and Sodium Starch Glycolate (DST) new plants completed, bolstering Yung Zip’s production capacity further.
●Cooperation with the government for liquid crystal materials development.

●Ministry of Economic Affairs, industry development "low drive voltage color LCD special product technology development" project.

2000

●Yung Zip is listed on the stock market.

1990s

1999

●Listed in Common Wealth Magazine (天下雜誌) best selection of the world's top 100 companies in the past three years, ranked 77th in the top growth rate over three years, ranked 22nd for return on shareholders' equity.

1998

●Won National Pharmaceutical Quality Award of 1998.。

1997

●Ministry of Finance approved the public offering of shares.

●Completion of multi-functional distillation tower.

1995

●Passed general US FDA API facility GMP inspection (3rd inspection).

1994

●Apply for domestic GMP inspection factory (inspected by the Drug Inspection Bureau of the Department of Health), Yung Zip is the leader in GMP API production in Taiwan.

1992

●Passed general US FDA API facility GMP inspection (2nd inspection).

1990

●Construction of methanol recovery distillation tower completed, milestone in increasing efficiency and environmental production.。

●Applied for the first inspection by the US Food and Drug Administration.

1980s

1986

●Construction of third factory completed.

1981

●Construction of second factory completed。

1980

●Construction of first factory completed and operations begin, the official beginning of Yung Zip products benefiting the society.

1970s

1978

●Mr. Fang-yu Lee, the founder of the company, set up “Yung Zip Chemical Ind. Co., Ltd.” in June 1978 in view of the importance of API development on pharmaceutical manufacturing industry and the promotion of industrial technology in Taiwan.